Enkephalin degradating enzymes in pheochromocytoma patients

  • Authors:
    • Tihomir Balog
    • Tatjana Marotti
    • Visnja Sverko
    • Miljenko Marotti
    • Ivan Krolo
    • Boris Rocic
    • Nikola Karapanda
  • View Affiliations

  • Published online on: January 1, 2003     https://doi.org/10.3892/or.10.1.253
  • Pages: 253-258
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Adrenal gland as a major source of enkephalins on the periphery can be affected by a rare adrenal gland tumor, adrenal pheochromocytoma. It has been demonstrated that this tumor might be associated with altered concentration of enkephalin-like peptides. The effect of these peptides can be either prolonged or abbreviated by two neutrophil membrane bound enzymes; aminopeptidase N (APN) and neutral endopeptidase (NEP). We assumed that altered enkephalin level in pheochromocytoma patients (but not in patients with non-functional adenomas or tumors of different origin) might result in differently regulated APN and/or NEP activity. We measured APN and NEP activity on surface of neutrophils, level of lipid peroxidation (LPO) in plasma and enkephalin concentration in plasma in patients with pheochromocytomas, non-functional adenomas, malignant renal tumors and healthy controls. Catheholamines and vanyllmandelic acid (VMA) were measured in 24-h urine of pheochromocytoma patients. NEP and APN activity on neutrophils from all pheochromocytoma patients was significantly increased as compared with healthy controls, non-functional adenomas and malignant renal tumors. In all pheochromocytoma patients NEP activity was reduced almost to the control level after surgery. At the same time APN activity was in some patients up- and in others down-regulated. In comparison, elevated levels of cateholamines and VMA were found after multiple determinations in 6 out of 10 pheochromocytoma patients. Although preliminary, this study has shown specifically and consistently up-regulated NEP activity on neutrophils from pheochromocytoma patients, and uniformly decreased NEP activity in these patients after adrenalectomy.

Related Articles

Journal Cover

January-February 2003
Volume 10 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Balog T, Marotti T, Sverko V, Marotti M, Krolo I, Rocic B and Karapanda N: Enkephalin degradating enzymes in pheochromocytoma patients. Oncol Rep 10: 253-258, 2003
APA
Balog, T., Marotti, T., Sverko, V., Marotti, M., Krolo, I., Rocic, B., & Karapanda, N. (2003). Enkephalin degradating enzymes in pheochromocytoma patients. Oncology Reports, 10, 253-258. https://doi.org/10.3892/or.10.1.253
MLA
Balog, T., Marotti, T., Sverko, V., Marotti, M., Krolo, I., Rocic, B., Karapanda, N."Enkephalin degradating enzymes in pheochromocytoma patients". Oncology Reports 10.1 (2003): 253-258.
Chicago
Balog, T., Marotti, T., Sverko, V., Marotti, M., Krolo, I., Rocic, B., Karapanda, N."Enkephalin degradating enzymes in pheochromocytoma patients". Oncology Reports 10, no. 1 (2003): 253-258. https://doi.org/10.3892/or.10.1.253